Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Cogent Biosciences announced it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026 at 7:30 a.m. ET. A live webcast will be available on the company's investor relations site, with a replay archived for 30 days. Cogent also disclosed Nasdaq Rule 5635(c)(4) inducement grants to six new employees: options on 22,000 shares and 16,500 RSUs with standard 4-year vesting.
Key figures
- Inducement rsu count
- 16500
- New employees granted
- 6
- Inducement options shares
- 22000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.